Dot1L-IN-4
Dot1L-IN-4 is a potent disruptor of telomeric silencing 1-like protein (DOT1L) inhibitor with an IC50 SPA DOT1L of 0.11 nM[1].
Product Specifications
CAS Number
[2565705-02-2]
UNSPSC
12352005
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dot1l-in-4.html
Purity
99.67
Solubility
DMSO : ≥ 200 mg/mL
Smiles
O=S(C1=CC=C(N[C@H](C2=NC=CC=C2Cl)C3=C4OC(F)(F)OC4=CC=C3)C(NC5=NC(OC)=NC(N6CCNCC6)=N5)=C1)(C)=O
Molecular Formula
C28H27ClF2N8O5S
Molecular Weight
661.08
References & Citations
[1]Frédéric Stauffer, et al. New Potent DOT1L Inhibitors for in Vivo Evaluation in Mouse. ACS Med. Chem. Lett. 2019, 10, 12, 1655-1660.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DOT1L
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal TTBK1 Antibody [DyLight 405]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
![Rabbit Polyclonal MAGEB10 Antibody [DyLight 405]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
035051-ML650 100 µL
ELOVL5, CT (ELOVL5, ELOVL2, Elongation of very long chain fatty acids protein 5, 3-keto acyl-CoA synthase ELOVL5, ELOVL fatty acid elongase 5, Fatty acid elongase 1) (MaxLight 650) discontinued
Ask
View Details